The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Clavudale 200 mg/50 mg tablets for dogs

200/50 mg/tablet Tablet

Dechra Regulatory B.V.VPA22622/005/002

Main Information

Trade NameClavudale 200 mg/50 mg tablets for dogs
Active SubstancesAmoxicillin
Clavulanic acid
Strength200/50 mg/tablet
Dosage FormTablet
Licence HolderDechra Regulatory B.V.
Licence NumberVPA22622/005/002

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibacterial
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued15/04/2011
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back